Legend Biotech (LEGN) Intangibles (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Intangibles data on file, last reported at $2.1 million in Q2 2025.

• In Q2 2025, Intangibles fell 22.91% year-over-year to $2.1 million; the TTM figure through Jun 2025 stood at $2.1 million (down 22.91% YoY), while the FY2024 annual figure was $2.2 million, down 46.81% from the prior year.
• Intangibles improved to $2.1 million in Q2 2025, from $2.1 million in the prior quarter.
• Across five years, Intangibles topped out at $5.4 million in Q3 2021 and bottomed at -$1.7 million in Q4 2021.
• A 5-year average of $2.7 million and a median of $2.6 million in 2024 frame the typical range for Intangibles.
• The widest YoY moves for Intangibles: up 521205.18% in 2021, down 414.37% in 2021.
• Year by year, Intangibles stood at -$1.7 million in 2021, then jumped by 298.43% to $3.4 million in 2022, then climbed by 19.13% to $4.1 million in 2023, then tumbled by 46.81% to $2.2 million in 2024, then decreased by 1.06% to $2.1 million in 2025.
• The last three Intangibles figures came in at $2.1 million (Q2 2025), $2.1 million (Q1 2025), and $2.2 million (Q4 2024), per Business Quant data.

Peer Comparison